From: Glucose levels as a prognostic marker in patients with ST-segment elevation myocardial infarction: a case–control study
Groups of patients
Patients without adverse events, n
Time-to-onset, Me, the 25th and 75th percentiles
95 % CI
with hypoglycemia
0
2 (1–6) month
1.98 - 4.73
without hypoglycemia
6 (10.2 %)
3 (1–6) month
2.71 - 5.05